Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities

Academic Article
Publication Date:
2024
Short description:
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities / De Luca, G., Campochiaro, C., Palmisano, A., Bruno, E., Vignale, D., Peretto, G., Sala, S., Ferlito, A., Cilona, M.B., Esposito, A., Matucci-Cerinic, M., Dagna, L.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 63:7(2024), pp. 1902-1910. [10.1093/rheumatology/kead541]
abstract:
Objectives: Myocarditis is an overlooked manifestation of anti-synthetase syndrome (ASS). Our study describes the clinical and instrumental features of ASS-myocarditis and evaluates the diagnostic performance of cardiac magnetic resonance (CMR) with mapping techniques. Methods: Data from ASS-patients were retrospectively analyzed. CMR data of patients diagnosed with myocarditis, including late gadolinium enhancement (LGE), T2-ratio, T1-mapping, extra-cellular volume (ECV) and T2-mapping, were reviewed. Myocarditis was defined by the presence of symptoms of heart involvement with increased high-sensitive troponin T (hs-TnT) and/or NT-proBNP and at least an instrumental abnormality. Clinical features of ASS patients with and without myocarditis were compared. A p value<0.05 was considered. Results: Among a cohort of 43 ASS-patients (median age 58[48.0-66.0] years; females 74.4%; anti-Jo1 53.5%), 13(30%) were diagnosed with myocarditis. In 54% of patients, myocarditis was diagnosed at clinical onset. All ASS-myocarditis patients had at least one CMR abnormality: increased ECV in all cases, presence of LGE, increased T1 and T2-mapping in 91%. The 2009-Lake Louis criteria (LLC) were satisfied by 6 patients, the 2018-LLC by 10. With the updated LLC, the sensitivity for myocarditis improved from 54.6% to 91.0%. ASS-patients with myocarditis were more frequently males(53% vs 13%;p=0.009) with fever(69% vs 17%;p=0.001), and had higher hs-TnT (88.0[23.55-311.5] vs 9.80[5.0-23.0]ng/L; p < 0.001), NT-proBNP(525.5[243.5-1575.25] vs 59.0[32.0-165.5;p=0.013]pg/ml;p=0.013) and C-reactive protein(CRP)(7.0[1.7-15.75] vs 1.85[0.5-2.86]mg/L;p=0.011) compared to those without myocarditis. Conclusion: In ASS, myocarditis is frequent, even at clinical onset. ASS-patients with myocarditis frequently presented with fever and increased CRP, suggesting the existence of an inflammatory phenotype. The use of novel CMR mapping techniques may increase the diagnostic sensitivity for myocarditis in ASS.
Iris type:
1.1 Articolo in rivista
List of contributors:
De Luca, Giacomo; Campochiaro, Corrado; Palmisano, Anna; Bruno, Elisa; Vignale, Davide; Peretto, Giovanni; Sala, Simone; Ferlito, Arianna; Cilona, Maria Bernardette; Esposito, Antonio; Matucci-Cerinic, Marco; Dagna, Lorenzo
Authors of the University:
DAGNA LORENZO
DE LUCA GIACOMO
ESPOSITO ANTONIO
MATUCCI CERINIC MARCO
PALMISANO ANNA
VIGNALE DAVIDE
Handle:
https://iris.unisr.it/handle/20.500.11768/152996
Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/152996/189140/kead541.pdf
Published in:
RHEUMATOLOGY
Journal
  • Overview

Overview

URL

https://watermark.silverchair.com/kead541.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA5cwggOTBgkqhkiG9w0BBwagggOEMIIDgAIBADCCA3kGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM6l3PMM6UHsInQs6iAgEQgIIDSl7nrJWfnJVBqfr_ZDNy-JibAQcN-eXEMf-ScyPJeVTXy4bBwoANBwW0-H6qbFRO8jkuVRKl89Q0wV3ae8ER3TTRQ0rapL08eXPJYvSe7mNYt8fXkejusOUu65ccuNNtjDlMjjUl16IbXZPXJFO4PjTq-ZA_XHRfzkx3y7tJprzHodJemnGuOll8TiIm2OQ6qm3Ckcv9sjOeMny9Es2suPNpP5fLvi2FiNZpSi_qDiegwbxZY_GD2HHJkXKCeZzJddZv8GM-J65xbSu5hK9KFdFZth2E1fGHKFS0uPECYCZq6odYftaDS8UaI6T2LS5e1TfpTW6QZtC_bZZC2yCfFSywruzhd6CnV74aeG3ipNsjYOHNutJcaTaVaJsjyNKIhWNyvNrqKGWvUBBaNMk9ZrTY50UahhZIzutAlRw3_NNQnVesIPAky631Wx8_h_doOk1WEvUN0mOKoEEp-PCZZKAMZEYWQR57KJWREQeEes5dsVqbNYYIndxfXsDXf8I-9nTbzvDm9iLYzkE71v93endQQe6_8ijtB3WadwYEC25DioMX9Z_iG6ZC5_uHOSgL6tOGMEOpRcPzHRxZuhDLqQGTaraay0og6ips4x6xB2X6vM440nUxwG20oVrMv2VtJPRTUZoJFroCi70YwTMWO0nikgyQg01WEOW6_5PscHHX0W_jkC-MGy2gmJWMHdsMGTr-SmO2bQAYEWuoe4eK8eXphInFUZr2JW1jhavQf60vCQSRNfn8V__v1Qiwv4ViHjMEBsFrCUiDDq9JTJyytvuWHyNlf3t9-pcZmEHxvZwvPaLqb9wG9tQuO70hJCDYAGnGZle_M0r2r58zzP7i3sFk217v_fJboYwGsVO74bqWgNZqVfYMJHuNdQnWNiV80fSQ5RSozMVWTsonUQqWLlBSU78RKUdDy8JlVtN91ReDwhvR-cRtdGbxlTjFukvjg4e4dCGMU9iyJTCsOwJsvV0tn84on3VUIz7K9DYBWn0ee4RVuNzLQtICqqYgRwVbaM3ggifide4gjHz5-QjFbV5apuQzSt0dsBG3mm5hRQekrVcTcrQNUaA0BtqEZ05fVxnJ08wYcAMskEEn1t8WhiMTBXAr_EMsOkvF
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.2.0